
Stryker (SYK) Stock Forecast & Price Target
Stryker (SYK) Analyst Ratings
Bulls say
Stryker's operating margin improved by 110 basis points year-over-year, reaching 25.7%, which was slightly above consensus expectations of 25.5%. The company's gross margin also increased by 120 basis points year-over-year, reflecting efficiencies that contributed to strong financial performance. Stryker's ongoing execution with a diverse range of new products has resulted in notable revenue growth, enhancing its competitive position in the medical equipment market.
Bears say
Stryker's stock outlook is negatively impacted by an anticipated slowdown in organic revenue growth, projected to decline to 8% or less, driven by potential failures in new product launches and revenue dis-synergies from acquisitions. The company's management highlighted challenges, including weak sales from Inari Medical and issues related to sales rep turnover and destocking, which may hinder overall performance. Additionally, risks such as slower orthopedic market growth and declining hospital capital spending contribute to concerns regarding Stryker's future earnings and profitability, which could lead to earnings dilution.
This aggregate rating is based on analysts' research of Stryker and is not a guaranteed prediction by Public.com or investment advice.
Stryker (SYK) Analyst Forecast & Price Prediction
Start investing in Stryker (SYK)
Order type
Buy in
Order amount
Est. shares
0 shares